Sapiens Jumps on Sapiens Decision News
Sapiens International Corporation (NASDAQ: SPNS) shares began Wednesday in the green. The Rochelle Park, New Jersey-based company, a global leader in intelligent SaaS-based software solutions, today announced that Sapiens Decision has been named a Leader in The Forrester Wave™: AI Decisioning Platforms, Q2 2025. This recognition marks a significant milestone for Sapiens, positioning the company as a leader in an emerging, business-critical technology category that enables organizations to safely and effectively leverage AI for better decision-making and operational outcomes.Sapiens was evaluated among 15 providers in the highly competitive category of AI Decisioning Platforms, emerging as a leader based on the evaluation of its product capabilities, strategic vision, and other criteria. The company was cited for its ability to serve the sophisticated needs of highly regulated industries, such as insurance and financial services."We believe Forrester's recognition validates our long-standing commitment to delivering operational excellence and business agility through AI decisioning," said CEO Roni Al-Dor. "We're proud to be a leader in this strategically vital category and to help insurers and financial organizations optimize outcomes, control AI risks, and deliver measurable business value faster than ever before. With organizations facing growing pressures to modernize, adopt AI responsibly, and improve operations, Sapiens offers a proven, enterprise-grade solution that delivers scalable results."SPNS shares hiked 49 cents in the first hour, or 1.7%, to $30.10.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


